Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
well said bomba...i have waited a long time..certainly not willing to go the cheap expeditious route some folks who claim huge interests want to take us..very suspect..we are talking about a new platform to treat cancer and infectious disease..
checked several times..still empty..
looks like tutes more interested than ever
https://www.thecerbatgem.com/2017/01/10/adage-capital-partners-gp-l-l-c-continues-to-hold-position-in-advaxis-inc-adxs.html
OnePrettyLatinaMe: Dont Text Me Until I Fill My Profile
OnePrettyLatinaMe: Dont Text Me Until I Fill My Profile
anybody who has been around here long knows this road is rocky..but this year things should fall into place..with critical updates..we have been around a long time now..and the platform has been extended to other areas.. I think this is exciting..esp, with start of MINE..and HOT..I love where we are going and where we have been..this is a new platform for treating cancer..the ramifications are enormous ..like a whole new branch of medicine in some ways..requiring designer specialissts in future world.
..can anyone explain the difference between the current phase 3 axal study and the new phase 3 study for axal starting this year...also noticed the astra HPV trial included head and neck as well as cervical..looks like its on track all around..hpv, her2, psa, neon, adxs-hot, infectious disease, and parasitic infections..stock price aside I am HAPPY to be aboard..
eu approval of HPV as well as india, Latin America and perhaps CHina..and HER2 approval of dog vac + prostate update with merk + other hpv trial updates in anal and head and neck..dosing first MINE patient in start of phase 1..with payment from amgen..update on astra+HPV study..new frontier news on infectuous diseases..early start of HER2 testing in people ....2017 should rock for adxs.. and posters talk about 20 per share buyout..LOL>>LOL>>LOL..and this is off the top of my head. forgot to mention the rapidly improving biotech investment environment..
the old 20/20 hindsight ...but back when the deal was made..approval of the lm platform for any treatment option was a big if...once the her2 vac is commercialized we will see what the revenue is.... world wide distribution..could be its being too heavily discounted.
seems no one knows state of her2 animal treatment vaccine..except to say from all indicators its close to commercialization..we all know the speed of approval has been dissappointing..but thats a biotech reality..getting commercial approval for any vaccine manufactured off the LM platform will be significant achievement..your feelings on the neglected pet population aside..
fbg my point is most investors would not vote for a 20 dollar a share buyout.
Midteens before any real shares available to cover..even without news..with news and her2 for dogs commercialized..much higher I imagine..
First commercialized product weeks away..
Fbg you think our tutes will go for 1 billion buy out lol
with the article on pet vaccine in washington post last month..the behaviors of the stock..well i don't even want to say what is long long over due..imagine it would be a world wide distribution..what is the revenue potential..not just USA but global..? not to mention long awaited validation of the platform with a commercial product..probably hit 3.00 share price if that happens..lol.
Petx had a nice run last few days..could it be..you know.
Share price means nothing..no volume..may go up for few days before lows are revisited.
adxs vaccine technology has no doubt improved tremendously since the testing of HPV cervical phase 1 and phase 2 trials..and undoubtedly produces a better outcome than the old vaccines..are the phase 3 trials able to take advantage of these engineering advancements..or are they still in trials with the older static constructs.
Shorts are done when we get bought out..they do what they want and when they want,.we bounce on Tuesday..shorts..we go down same cause,.
blue if you are making the point that the warrant premiums are valid indicators I get it..but your daily bowl movements are really of no concern...
as you pointed out in another post..the current high premium on warrants while the stock derails looks like an attempt to keep the warrants out of play.but people are buying then anyway..i was gonna make a purchase towards the end of the day when they usually come down a little..but got distracted by other things..maybe Tuesday..
nice summary..iggie..this is a new technology for treating cancer..CHeaper and able to refine itself upon feedback and research. making it more effective..able to fill a world wide need for woman suffering not just in well off countries..validation is coming.we are getting close to our first commercial approvals.
wow..fbg.. i did not know this..thanks for keeping us uptodate with the ceo lol
when was the last time short interest was just 5 million shares..it has been around 9 million for the last year..
s/p stays down here I will be buying next week..good spread at these low prices.
what about the fact we are a baby bio..with no approved products..a very low float..and big short interest that has continued for months now with little signs of abating..all that is dan's fault..? despite the fact we have seen great progress..new partners..fast track..etc..seems odd to blame him..
given the market weakness i don't see why the share price should increase ..perfect time for short interest to test new lows..thinking the bottom will come in the first week in January..with some bouncing around faux increases..
fbg..given your assessment that dan is out to destroy the share price..how successful do you think he will be..and when do we see the bottom of the current erosion in price ..created by our CEO.
not that i am bottom fishing..but i have noticed this stock seems to hit a low point towards the end of the month then rise before going lower again..it would be nice to see that pattern continue esp at these prices..I am thinking think the price will continue trending down with weak demand and short interest perfectly aligned..perhaps to low 6s ..yet its hard to call a bottom as the whole thing is manufactured..but this seems a good time for shorts to see how low it can go...as they cautiously engineer this current erosion..
if dan's interest are not aligned with shareholders..then what are his interests and how is he benefiting ..?? and can any sane assessment of the current share price be his responsibility?? get real..
wheres the bottom..i make my monthly purchase next week..my interest is 6 months to a year out..
when and at what price this will play out is still uncertain.
there's a very focused short play now..feels very tightly managed..with downward play..bouncing along the bottom may be in the cards..
are the new treatment advances like MIME and HOT applicable to the current phase 3 trials...and could they be applied to this current phase 3 trial..and overall to the on going phase i and phase 2...maybe under some circumstances...
approved products are the ultimate in revenue no doubt..but along that road adxs as a research and development company has had several sources of revenue streams..to pay for that research..been pretty impressive actually...just a few more like that one from amgen and we will be good.
the LM platform is obviously a powerful research tool..the infectious disease pursuit could lead to some really nice government contracts to further research this using LM.
its the bio engineering expressed in programmable variations..certain formulations geared to specific expressions that has been observed..so i thing the vaccine is getting very accurate..
longs are passively grassing for now..
stock traded about 1/2 the already low average volume at these prices.
where would volume be on the way to 5..a few hundred shares...it seems obvious there is a big wait and see with adxs..but at these prices the risk/reward has got to be very compelling..this endless shaking the tree for shares has gotten old..but oh well..nothing more subtle than bashing the day before and during the price turn down...seen that more than once..
and very disappointed it did not happen later in the month..which it still may..
with 25% of the company sold short..about 1 in 4 shares traded daily likely to be a borrowed share..probably much higher..and 1 in 10 of those daily shares being used to cover....the marginal analysis is not good for short share interest..market will have to offset the decline in volume induced by shorts covering with price increases to induce selling...Only that has not really worked very well. and.most investors are now immune to the roller-coaster effect..and its late in the game to keep trying it.
as an interest side note..warrant short interest reached 18000 at the end of august..it is now 940...that could be a truer measure of sentiment than share short interest...
with shorts grabbing about 53000 shares a day to cover..at this price/volume ration..and sentiment increasingly bullish on this stock..look for increases in that price/volume ..negative posts on public boards is not going to have much effect on selling as that tactic has more than worn completely thin and produced very little availability..pumping volume to lower price isn't working very well either..so whats left..increasing price..but how much will it take..well it won't be cheap..if that were the case many of the shorts would no doubt have covered..postponing the inevitable while positive sentiment builds will inevitably cost more..and the current rally has yet to reach the bio sector..but its coming..
shorts managed to grab about 53000 shares a day to cover their position during end of November at this price/volume ratio..at this rate..With over 10 million short shares it will take them about 189 days to cover..LOL..no wonder we have some new buddies on the board..